Surmodics Inc's fundamentals are relatively healthy, Its valuation is considered fairly valued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as Sell, with the highest price target at max_target_price.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.
Surmodics Inc's Score
Industry at a Glance
Industry Ranking
77 / 209
Overall Ranking
183 / 4596
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
43.000
Target Price
+47.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Surmodics Inc Highlights
StrengthsRisks
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 26.14% year-on-year.
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.95M shares, decreasing 24.21% quarter-over-quarter.
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Ticker SymbolSRDX
CompanySurmodics Inc
CEOHance (Robert B)
Websitehttps://www.surmodics.com/
FAQs
What is the current price of Surmodics Inc (SRDX)?
The current price of Surmodics Inc (SRDX) is 42.980.
What is the symbol of Surmodics Inc?
The ticker symbol of Surmodics Inc is SRDX.
What is the 52-week high of Surmodics Inc?
The 52-week high of Surmodics Inc is 42.890.
What is the 52-week low of Surmodics Inc?
The 52-week low of Surmodics Inc is 25.870.
What is the market capitalization of Surmodics Inc?
The market capitalization of Surmodics Inc is 614.53M.
What is the net income of Surmodics Inc?
The net income of Surmodics Inc is -11.54M.
Is Surmodics Inc (SRDX) currently rated as Buy, Hold, or Sell?
According to analysts, Surmodics Inc (SRDX) has an overall rating of --, with a price target of 43.000.
What is the Earnings Per Share (EPS TTM) of Surmodics Inc (SRDX)?
The Earnings Per Share (EPS TTM) of Surmodics Inc (SRDX) is -1.237.